Nagayama Hiroshi, Kubo Shin-ichiro, Hatano Taku, Hamada Shinsuke, Maeda Tetsuya, Hasegawa Takafumi, Kadowaki Taro, Terashi Hiroo, Yoshioka Masayuki, Nomoto Nobuatsu, Kano Osamu, Inoue Manabu, Shimura Hideki, Takahashi Tatsuya, Uchiyama Tsuyoshi, Watanabe Hirohisa, Kaneko Satoshi, Takahashi Tetsuya, Baba Yasuhiko
Department of Internal Medicine, Division of Neurology, Nephrology and Rheumatology, Nippon Medical School, Japan.
Intern Med. 2012;51(8):865-9. doi: 10.2169/internalmedicine.51.6718. Epub 2012 Apr 15.
Anhedonia is one of the main non-motor symptoms in Parkinson's disease (PD); it is assessed using the Snaith-Hamilton pleasure scale (SHAPS). To assess anhedonia in the Japanese population, we prepared a Japanese language version of SHAPS (SHAPS-J), and evaluated its validity and reliability in 8 neurological centers. Seventy subjects (48 patients with PD and 22 healthy subjects) were enrolled in this study.
The validity of the test was assessed by the correlation between SHAPS-J and the apathy scale, based on the fact that anhedonia is considered a symptom of apathy syndrome. Test-retest reliability and internal consistency were assessed by Cohen's kappa and Cronbach's alpha coefficients, respectively.
In the evaluation of validity, the total scores obtained on SHAPS-J during the test and retest significantly correlated with scores on Item 4 in Part 1 of the unified Parkinson's disease rating scale (p<0.0008 and p<0.0036, respectively). Cohen's kappa coefficient was >0.3 on all items (p<0.0005 on all items). Cronbach's alpha coefficient was 0.90 at the baseline and 0.88 at the retest.
These results indicate that SHAPS-J has good validity, test-retest reliability, and internal consistency, thus establishing an available measure of anhedonia in Japanese.
快感缺失是帕金森病(PD)的主要非运动症状之一;使用斯奈斯 - 汉密尔顿愉悦量表(SHAPS)对其进行评估。为了评估日本人群中的快感缺失情况,我们编制了SHAPS的日语版本(SHAPS - J),并在8个神经科中心评估了其有效性和可靠性。本研究纳入了70名受试者(48例帕金森病患者和22名健康受试者)。
基于快感缺失被认为是淡漠综合征的一种症状这一事实,通过SHAPS - J与淡漠量表之间的相关性来评估该测试的有效性。分别通过科恩kappa系数和克朗巴赫alpha系数评估重测信度和内部一致性。
在有效性评估中,测试和重测期间SHAPS - J获得的总分与统一帕金森病评定量表第1部分项目4的得分显著相关(分别为p<0.0008和p<0.0036)。所有项目的科恩kappa系数均>0.3(所有项目p<0.0005)。基线时克朗巴赫alpha系数为0.90,重测时为0.88。
这些结果表明SHAPS - J具有良好的有效性、重测信度和内部一致性,从而建立了一种可用于评估日本人群快感缺失的方法。